JP2014519955A5 - - Google Patents

Download PDF

Info

Publication number
JP2014519955A5
JP2014519955A5 JP2014517085A JP2014517085A JP2014519955A5 JP 2014519955 A5 JP2014519955 A5 JP 2014519955A5 JP 2014517085 A JP2014517085 A JP 2014517085A JP 2014517085 A JP2014517085 A JP 2014517085A JP 2014519955 A5 JP2014519955 A5 JP 2014519955A5
Authority
JP
Japan
Prior art keywords
drug delivery
transdermal drug
delivery system
sensitive adhesive
adhesive layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014517085A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014519955A (ja
JP6296977B2 (ja
Filing date
Publication date
Priority claimed from US13/164,037 external-priority patent/US8900626B2/en
Application filed filed Critical
Publication of JP2014519955A publication Critical patent/JP2014519955A/ja
Publication of JP2014519955A5 publication Critical patent/JP2014519955A5/ja
Application granted granted Critical
Publication of JP6296977B2 publication Critical patent/JP6296977B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014517085A 2011-06-20 2012-06-19 経皮薬物送達システムおよびその使用方法 Expired - Fee Related JP6296977B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/164,037 2011-06-20
US13/164,037 US8900626B2 (en) 2011-06-20 2011-06-20 Transdermal drug delivery system and method of using the same
PCT/US2012/043126 WO2012177626A1 (en) 2011-06-20 2012-06-19 Transdermal drug delivery system and method of using the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016202990A Division JP2017048201A (ja) 2011-06-20 2016-10-14 経皮薬物送達システムおよびその使用方法

Publications (3)

Publication Number Publication Date
JP2014519955A JP2014519955A (ja) 2014-08-21
JP2014519955A5 true JP2014519955A5 (enExample) 2015-05-21
JP6296977B2 JP6296977B2 (ja) 2018-03-20

Family

ID=47353860

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014517085A Expired - Fee Related JP6296977B2 (ja) 2011-06-20 2012-06-19 経皮薬物送達システムおよびその使用方法
JP2016202990A Pending JP2017048201A (ja) 2011-06-20 2016-10-14 経皮薬物送達システムおよびその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016202990A Pending JP2017048201A (ja) 2011-06-20 2016-10-14 経皮薬物送達システムおよびその使用方法

Country Status (9)

Country Link
US (1) US8900626B2 (enExample)
EP (1) EP2720748B1 (enExample)
JP (2) JP6296977B2 (enExample)
KR (2) KR20190026963A (enExample)
CN (1) CN103429295B (enExample)
CA (1) CA2831095C (enExample)
ES (1) ES2627514T3 (enExample)
MX (1) MX347195B (enExample)
WO (1) WO2012177626A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120035220A (ko) * 2003-01-22 2012-04-13 센주 세이야꾸 가부시키가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환 치료약의 눈의 국소 조직으로의 이행 방법
US20070060988A1 (en) 2005-07-18 2007-03-15 Grenon Stephen M Melting meibomian gland obstructions
US20090043365A1 (en) 2005-07-18 2009-02-12 Kolis Scientific, Inc. Methods, apparatuses, and systems for reducing intraocular pressure as a means of preventing or treating open-angle glaucoma
US8950405B2 (en) * 2006-05-15 2015-02-10 Tearscience, Inc. Treatment of obstructive disorders of the eye or eyelid
US20070016256A1 (en) * 2005-07-18 2007-01-18 Korb Donald R Method and apparatus for treating gland dysfunction
WO2013003594A2 (en) 2011-06-28 2013-01-03 Tearscience, Inc. Methods and systems for treating meibomian gland dysfunction using radio-frequency energy
US20080114423A1 (en) 2006-05-15 2008-05-15 Grenon Stephen M Apparatus for inner eyelid treatment of meibomian gland dysfunction
US7981145B2 (en) 2005-07-18 2011-07-19 Tearscience Inc. Treatment of meibomian glands
US9314369B2 (en) 2006-05-15 2016-04-19 Tearscience, Inc. System for inner eyelid treatment of meibomian gland dysfunction
US10842670B2 (en) 2012-08-22 2020-11-24 Johnson & Johnson Vision Care, Inc. Apparatuses and methods for diagnosing and/or treating lipid transport deficiency in ocular tear films, and related components and devices
US9211397B2 (en) * 2012-12-19 2015-12-15 Senju Usa, Inc. Patch for treatment of eyelid disease containing clobetasol
US9820954B2 (en) 2015-08-19 2017-11-21 Jenivision Inc. Quantitative peri-orbital application of ophthalmology drugs
US12029681B2 (en) 2016-03-01 2024-07-09 The Hilsinger Company Parent, Llc Therapeutic eye mask system
US12011388B2 (en) 2016-03-01 2024-06-18 The Hilsinger Company Parent, Llc Therapeutic thermal compress with phase-change material
US12156831B2 (en) 2016-03-01 2024-12-03 The Hilsinger Company Parent, Llc Therapeutic eye compress system
JP7183041B2 (ja) * 2016-06-29 2022-12-05 センジュ ユーエスエー、インコーポレイテッド 経皮薬物送達システムおよびその使用方法
USD844795S1 (en) 2016-11-30 2019-04-02 Bruder Healthcare Company, Llc Therapeutic eye mask
USD871598S1 (en) 2016-11-30 2019-12-31 Bruder Healthcare Company, Llc Therapeutic eye mask
US11759472B2 (en) 2017-11-21 2023-09-19 Cs Pharmaceuticals Limited Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface
CA3080166A1 (en) 2017-11-21 2019-05-31 Axerovision, Inc. Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface
JP7332602B2 (ja) * 2017-12-28 2023-08-23 センジュ ユーエスエー、インコーポレイテッド 経皮薬物送達システムおよびその使用方法
EP3758657A4 (en) * 2018-03-02 2022-01-19 The Schepens Eye Research Institute, Inc. SYSTEM AND METHOD OF TREATMENT OF MEIBOMAN GLAND DYSFUNCTION
WO2022010864A1 (en) * 2020-07-06 2022-01-13 Kindeva Drug Delivery L.P. Drug delivery device for delivery of clobetasol propionate
CA3199736A1 (en) 2020-11-23 2022-05-27 Sight Sciences, Inc. Formulations and methods for treating conditions of the eye

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1047519A (en) 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡,21-diesters of 11,17,21-trihydroxy steroid compounds
GB1253831A (en) 1968-01-19 1971-11-17 Glaxo Lab Ltd 9alpha,21-DIHALOPREGNANE COMPOUNDS
ZA744259B (en) 1973-08-17 1975-06-25 American Cyanamid Co Topical steroid
US4666441A (en) 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US4954343A (en) * 1986-03-29 1990-09-04 Nitto Electric Industrial Co., Ltd. Dermal pharmaceutical preparations
WO1989003390A1 (en) 1987-10-13 1989-04-20 Bodor Nicholas S Soft steroids having anti-inflammatory activity
ZA966579B (en) * 1995-08-04 1998-02-02 Wakamoto Pharma Co Ltd O/W emulsion composition for eye drops.
JP2001009985A (ja) * 1999-07-02 2001-01-16 Hisamitsu Pharmaceut Co Inc 貼付剤用包装袋及び包装貼付剤
WO2001026648A1 (en) 1999-10-13 2001-04-19 Senju Pharmaceutical Co., Ltd. Ophthalmic adhesive preparations for percutaneous absorption
US20050058695A1 (en) * 2002-05-30 2005-03-17 Watson Pharmaccuticals, Inc. Norethindrone sustained release formulations and methods associated therewith
KR20120035220A (ko) * 2003-01-22 2012-04-13 센주 세이야꾸 가부시키가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환 치료약의 눈의 국소 조직으로의 이행 방법
CA2562356A1 (en) * 2004-04-08 2005-10-27 Retmed Pty Ltd Treatment of ophthalmic conditions with mineralcorticoids
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
JP4308255B2 (ja) 2004-05-21 2009-08-05 千寿製薬株式会社 ムスカリン受容体作動薬を含有する眼科用経皮吸収型製剤
US20100160293A1 (en) 2005-02-17 2010-06-24 Kakuji Tojo Solid Ophthalmic Drug for External Use
AU2006235565A1 (en) * 2005-04-11 2006-10-19 The Board Of Trustees Of The Leland Stanford Junior University Multi-layer structure having a predetermined layer pattern including an agent
CN101217948A (zh) 2005-07-08 2008-07-09 千寿制药株式会社 包含依匹那丁的透皮吸收眼科制剂
EP1901708B1 (en) 2005-07-08 2013-09-11 Senju Pharmaceutical Co., Ltd. Percutaneously absorptive ophthalmic preparation comprising olopatadine
JPWO2007013661A1 (ja) 2005-07-26 2009-02-12 千寿製薬株式会社 眼科用経皮吸収型製剤
WO2008026756A1 (en) 2006-08-28 2008-03-06 Senju Pharmaceutical Co., Ltd. Ophthalmic percutaneous absorption type preparation
US20110028880A1 (en) 2008-02-27 2011-02-03 Hisamitsu Pharmaceutical Co., Inc. Patch
US20090297590A1 (en) 2008-05-30 2009-12-03 Masahiro Yamaji Ketotifen transdermal drug delivery systems and methods for treating ophthalmic disease
US8383595B2 (en) * 2008-06-19 2013-02-26 Kinki University Peptide derivative and composition for promoting tear secretion comprising the same
US10201548B2 (en) 2009-03-06 2019-02-12 Sun Pharma Global Fze Methods for treating ocular inflammatory diseases
TW201039815A (en) * 2009-04-13 2010-11-16 Resolvyx Pharmaceuticals Inc Compositions and methods for the treatment of inflammation
JO3257B1 (ar) * 2009-09-02 2018-09-16 Novartis Ag مركبات وتركيبات كمعدلات لفاعلية tlr
EP2493475A4 (en) 2009-10-30 2014-10-29 Intratus Inc COSMETIC METHODS AND PREPARATIONS FOR THE PROLONGED RELEASE OF THERAPEUTIC AGENTS IN THE EYE
WO2011120719A1 (de) * 2010-03-31 2011-10-06 Kiekert Ag Stellantrieb für ein kraftfahrzeug sowie verriegelungseinrichtung nebst verfahren
EP2505618A1 (en) * 2011-04-01 2012-10-03 Fábrica Nacional De Moneda Y Timbre Use of electromagnetic wave absorbing markers for the aunthentication of security documents

Similar Documents

Publication Publication Date Title
JP2014519955A5 (enExample)
MX347195B (es) Sistema de administración transdérmica de fármacos y método para usar el mismo.
AR093481A1 (es) Parche de varios dias para la administracion transdermica de rotigotina
SG194155A1 (en) Multilayer thin film drug delivery device and methods of making and using the same
IN2014DN09817A (enExample)
EP4461326A3 (en) Flexible system for delivering an anchor
WO2014116650A3 (en) Transdermal drug delivery system and method
CL2012002175A1 (es) Composicion farmaceutica oral de liberacion prolongada que comprende un agente activo de fracciones de propargilamina y aminoindano; metodo de preparacion; uso en el tratamiento de enfermedades neurodegenerativas o lesiones en el sistema nervioso tales como parkinson o alzheimer, un accidente cerebrovascular o lesion traumatica cerebral.
MX2016008138A (es) Sistema para el suministro transdermico de ingredientes activos.
AR087744A1 (es) Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
IN2012DN01225A (enExample)
WO2015140172A3 (en) A medicament for use in a method of inducing or extending a cellular cytotoxic immune response
MX2016002408A (es) Metodos para el tratamiento de trastornos oticos pediatricos.
MX382776B (es) Uso de levocetirizina y montelukast en el tratamiento de lesion traumatica.
TWD203509S (zh) 導管貼片
TWD159363S (zh) 藥布貼片
WO2016149077A3 (en) Fentanyl transdermal delivery system
TWD188084S (zh) 導管貼片
EA201490390A1 (ru) Вспомогательное средство для накладывания
CN202311196U (zh) 一种对足后跟皮肤皲裂有辅助治疗作用的袜子
BR112016015281A8 (pt) uso de um filtro em linha intravenoso, e método para preparação de um conjunto de infusão
US20170210086A1 (en) Painless medical adhesive tape easy to be torn
Hasan et al. Modulation Of NF-? B (p65) Activation By Enantiomers Of Formoterol In Human Airway Smooth Muscle Cells
Fediv et al. HYPOLYPEDEMIC THERAPY IN COMPLEX TREATMENT OF BRONCHIAL ASTHMA COMBINED WITH OBESITY, WITH REGARD TO POLYMORPHISM OF GENES
EP3386450A4 (en) INDEX FOR QUANTIFYING THE BOWMAN LAYER FOR THE DIAGNOSIS OF DISEASES AND THE PROGNOSIS OF TREATMENTS IN THE HUMAN BONE